Email
Print
ShareNew Delhi: Drugmaker Jubilant Organosys expects to sell off its performance polymers business by end March, its chairman said on Sunday.
In October, Jubilant said it would hive off the unit, which has annual sales of about Rs1.5 bn, as it plans to focus on its core pharmaceutical business.
"There is a lot of interest shown by both Indian and multinational companies," Shyam Bhartia said on the sidelines of the World Economic Forum's India Economic Summit.
Bhartia declined to name any of the suitors. Kotak is advising Jubilant on the deal and Bhartia said they would put a price on the unit by December.
